Regeneron: Driven by Science
For over 25 years, Regeneron's vision has been to build an innovative company that consistently brings new medicines to patients with serious diseases.
Regeneron to Report Third Quarter 2015 Financial and Operating Results and Host Conference Call and Webcast on November 4, 201510/08/15
TARRYTOWN, N.Y., Oct. 8, 2015 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its third quarter 2015 financial and operating results on Wednesday, November 4, 2015, before the U.S. financial markets open. The Company will host a conference call and...